LMCPX
Price
$33.31
Change
+$0.42 (+1.28%)
Updated
Dec 3 closing price
Net Assets
1.13B
VEVYX
Price
$46.94
Change
+$0.45 (+0.97%)
Updated
Dec 3 closing price
Net Assets
16B
Interact to see
Advertisement

LMCPX vs VEVYX

Header iconLMCPX vs VEVYX Comparison
Open Charts LMCPX vs VEVYXBanner chart's image
Lord Abbett Mid Cap Stock P
Price$33.31
Change+$0.42 (+1.28%)
VolumeN/A
Net Assets1.13B
Victory Sycamore Established Value Y
Price$46.94
Change+$0.45 (+0.97%)
VolumeN/A
Net Assets16B
LMCPX vs VEVYX Comparison Chart in %
View a ticker or compare two or three
VS
LMCPX vs. VEVYX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LMCPX is a Hold and VEVYX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEVYX has more cash in the bank: 16B vs. LMCPX (1.13B). VEVYX pays higher dividends than LMCPX: VEVYX (1.02) vs LMCPX (0.35). LMCPX was incepted earlier than VEVYX: LMCPX (28 years) vs VEVYX (13 years). LMCPX (1.22) is less costly to investors than VEVYX (0.66). LMCPX is a more actively managed with annual turnover of: 53.00 vs. VEVYX (34.00). LMCPX has a lower initial minimum investment than VEVYX: LMCPX (0) vs VEVYX (1000000). LMCPX (-11.56) and VEVYX (-12.07) have marching annual gain over last year. LMCPX return over 5 years is better than : 21.28 vs. VEVYX (18.34).
LMCPXVEVYXLMCPX / VEVYX
Total Expense Ratio1.220.66185%
Annual Report Gross Expense Ratio1.220.66185%
Fund Existence28 years13 years-
Gain YTD3.1272.945106%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.13B16B7%
Annual Yield % from dividends0.351.0235%
Returns for 1 year-11.56-12.0796%
Returns for 3 years11.80-1.61-734%
Returns for 5 years21.2818.34116%
Returns for 10 years39.4348.7181%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RADX4.490.26
+6.03%
Radiopharm Theranostics Limited
KD26.300.66
+2.57%
Kyndryl Holdings
ELVN21.000.44
+2.14%
Enliven Therapeutics
SBXD10.53-0.01
-0.09%
SilverBox Corp IV
BTI57.51-0.42
-0.73%
British American Tobacco plc